Search

Search Results
Results 4631 - 4640 of 4977 for Movement Disorder
  • Mizart HCT (New)
    Drug - 23 Oct 2025
    Consumer Medicine Information (CMI) about Mizart HCT (New) intended for persons living in Australia.
  • Retevmo
    Drug - 21 Oct 2025
    Consumer Medicine Information (CMI) about Retevmo intended for persons living in Australia.
  • Vaxelis
    Drug - 1 Oct 2025
    Consumer Medicine Information (CMI) about Vaxelis intended for persons living in Australia.
  • Minims Chloramphenicol
    Drug - 22 Sep 2025
    Consumer Medicine Information (CMI) about Minims Chloramphenicol intended for persons living in Australia.
  • Abstral sublingual tablets
    Drug - 16 Sep 2025
    Consumer Medicine Information (CMI) about Abstral sublingual tablets intended for persons living in Australia.
  • New World Screwworm: Re-Emergence in the Americas and Prevention Efforts
    Health - 26 Aug 2025
    New World screwworm has re-emerged in Central America and Mexico, raising concerns about human and animal health. Coordinated eradication efforts and new treatments are critical to prevent its spread...
  • C-Flox
    Drug - 25 Aug 2025
    Consumer Medicine Information (CMI) about C-Flox intended for persons living in Australia.
  • Kymriah
    Drug - 15 Aug 2025
    Consumer Medicine Information (CMI) about Kymriah intended for persons living in Australia.
  • Blincyto
    Drug - 12 Aug 2025
    Consumer Medicine Information (CMI) about Blincyto intended for persons living in Australia.
  • Triumeq
    Drug - 11 Aug 2025
    Consumer Medicine Information (CMI) about Triumeq intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback